Results 1 to 10 of about 8,503,937 (347)

Cardiovascular risk and cardiovascular risk factors in adolescents.

Revista Brasileira de Enfermagem, 2022
OBJECTIVES to identify cardiovascular risk and cardiovascular risk factors in adolescents and verify correlations between these variables and biochemical markers, and between blood pressure percentiles, Body Mass Index, and biochemical markers ...
Emília Soares Chaves Rouberte, T. Araújo, D. F. Sousa, Daiany Maria Castro Nogueira, Rebecca Silveira Maia, R. P. Moreira, Ederson Laurindo Holanda de Sousa, Livia Mara Bezerra Pinto   +7 more
semanticscholar   +4 more sources

Cardiovascular risk and obesity [PDF]

Diabetology & Metabolic Syndrome, 2019
BackgroundThis is an overview of the mechanisms of obesity and its relation to cardiovascular risks, describing the available treatment options to manage this condition.Main bodyThe pathogenesis of obesity includes the balance between calories consumed ...
C. Cercato, F. Fonseca
semanticscholar   +5 more sources

Hydroxytyrosol-Rich Olive Extract for Plasma Cholesterol Control

Applied Sciences, 2022
Emerging research and epidemiological studies established the health benefits of the Mediterranean diet, whose hallmark is the high consumption of olives and olive oil as the primary source of dietary fatty acids and major sources of antioxidants.
Arrigo F. G. Cicero, Federica Fogacci, Antonio Di Micoli, Maddalena Veronesi, Elisa Grandi, Claudio Borghi   +5 more
doaj   +1 more source

Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study

Applied Sciences, 2022
Recently released position papers by the European Society of Hypertension (ESH) and the Italian Society of Hypertension (SIIA) provide therapeutic recommendations for the use of nutraceuticals in the management of high blood pressure (BP) and ...
Federica Fogacci, Antonio Di Micoli, Elisa Grandi, Giulia Fiorini, Claudio Borghi, Arrigo F. G. Cicero   +5 more
doaj   +1 more source

Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebo controlled, double-blind clinical trial

Archives of Medical Science, 2023
Introduction In addition to healthy lifestyle and balanced diet, nutraceutical supplementation may be useful to maintain overall metabolic wellness.
Federica Fogacci, Marina Giovannini, Edigio Imbalzano, Elisa Grandi, Elisabetta Rizzoli, Sergio D'Addato, Arrigo F.G. Cicero   +6 more
doaj   +1 more source

Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting

Biomedicines, 2023
High lipoprotein(a) (Lp(a)) plasma levels are significantly associated with an increased risk of developing atherosclerotic cardiovascular diseases (ASCVD).
Arrigo F. G. Cicero, Federica Fogacci, Marina Giovannini, Elisa Grandi, Sergio D’Addato, Claudio Borghi   +5 more
doaj   +1 more source

Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease

Circulation Research, 2023
Hypertension is the leading modifiable cause of premature death and hence one of the global targets of World Health Organization for prevention. Hypertension also affects the great majority of patients with chronic kidney disease (CKD). Both hypertension
M. Burnier, A. Damianaki
semanticscholar   +1 more source

Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial

Archives of Medical Science, 2022
Introduction Bergamot and opuntia (prickly pear cladodes) standardized extracts have been demonstrated to have positive metabolic effects in preclinical and clinical models. Material and methods The aim of this study was to evaluate the metabolic effect
Federica Fogacci, Valentina Di Micoli, Maddalena Veronesi, Arrigo F.G. Cicero   +3 more
doaj   +1 more source

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

New England Journal of Medicine, 2022
BACKGROUND High triglyceride levels are associated with increased cardiovascular risk, but whether reductions in these levels would lower the incidence of cardiovascular events is uncertain.
Aruna Das Pradhan, R. Glynn, J. Fruchart, Jean G Macfadyen, Elaine Zaharris, Brendan M. Everett, Stuart E. Campbell, Ryu Oshima, P. Amarenco, D. Blom, E. Brinton, R. Eckel, M. Elam, J. Felício, H. Ginsberg, A. Goudev, Shun Ishibashi, Jacob Joseph, T. Kodama, W. Koenig, L. Leiter, A. Lorenzatti, B. Mankovsky, N. Marx, B. Nordestgaard, D. Páll, K. Ray, Raul D. Santos, H. Soran, A. Susekov, M. Tendera, K. Yokote, N. Paynter, J. Buring, P. Libby, P. Ridker   +35 more
semanticscholar   +1 more source

Prevalence of cardiovascular risk factors in patients with psoriasis.

Central European Journal of Public Health, 2022
OBJECTIVES The main goal of the study was to describe the demographic, epidemiological, clinical and laboratory characteristics of a monitored group of patients with psoriasis to assess the prevalence of cardiovascular comorbidities and to define the ...
Tomáš Kampe, E. Dorko, K. Rimárová, Andrea Houžvičková, J. Baloghová, Zuzana Baranová, Matúš Madleňák, Igor Rohoň   +7 more
semanticscholar   +1 more source